CD14 and neoplasm: For the APC panel, FAUST identified several tumour-enriched phenotypes of CD14+ cells, cDC2s and cDC3s marked by co-expression of CD40 and PD-L1 (Extended Data Fig. 2d, e, g), resembling an activated APC phenotype.